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INFECTION IN A VISCERAL LEISHMANIASIS-ENDEMIC AREA
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SUMMARY
The diagnosis of asymptomatic infection with Leishmania (Leishmania) chagasi has become more important over recent years. 
Expansion of visceral leishmaniasis might be associated with other routes of transmission such as transfusion, congenital or even 
vector transmission, and subjects with asymptomatic infection are potential reservoirs. Moreover, the identification of infection may 
contribute to the management of patients with immunosuppressive conditions (HIV, transplants, use of immunomodulators) and to 
the assessment of the effectiveness of control measures. In this study, 149 subjects living in a visceral leishmaniasis endemic area 
were evaluated clinically and submitted to genus-specific polymerase chain reaction (PCR), serological testing, and the Montenegro 
skin test. Forty-nine (32.9%) of the subjects had a positive PCR result and none of them developed the disease within a follow-up 
period of three years. No association was observed between the results of PCR, serological and skin tests. A positive PCR result in 
subjects from the endemic area did not indicate a risk of progression to visceral leishmaniasis and was not associated with a positive 
result in the serological tests.
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INTRODUCTION
Molecular biology techniques are used increasingly for the diagnosis 
of different forms of leishmaniasis. Peripheral blood-based polymerase 
chain reaction (PCR) assays can be applied to the diagnosis of human 
visceral leishmaniasis (VL), but better results have been obtained with 
bone marrow or spleen aspirates. Studies have reported variable sensitivity 
and specificity of this technique, reaching almost 100% for the diagnosis 
of symptomatic human cases1,5,11,17,18,19,23,26. In immunosuppressed patients, 
particularly those with acquired immunodeficiency syndrome (AIDS), the 
diagnosis of human VL by serological methods has yielded unsatisfactory 
results and PCR has been proposed as a good alternative10,12,20.
Although the existence of subjects suffering from asymptomatic 
Leishmania infection has been recognized, it is difficult to prove. The 
methods commonly used for identification of the parasite are not justified 
in asymptomatic cases because of the risks or discomfort to the individual. 
Immunological tests are widely used for the diagnosis of subclinical 
kala-azar, but there is no consensus regarding the interpretation of the 
results22,25. In this respect, PCR also serves to identify subjects with a 
positive test for human VL who live in endemic areas and show no signs 
or symptoms of the disease9,23,27.
The objective of the present study was to evaluate the evolution of 
subjects living in a VL-endemic area who have positive PCR results for 
Leishmania in peripheral blood.
PATIENTS AND METHODS
Patients: The study was conducted in the Municipality of Porteirinha, 
a northern region of the state of Minas Gerais, Brazil. This area is endemic 
for VL and cases of tegumentary leishmaniasis are rare.
In 1998, a total of 1,241 residents of this endemic area were submitted 
to anamnesis, clinical examination, and blood collection for serological 
testing. These subjects also underwent delayed hypersensitivity testing 
(Montenegro skin test, MST)22. In addition, peripheral blood was 
collected from a portion of this population (n = 149) for genus-specific 
PCR. 
The subjects of the study were reassessed clinically 3-4 years after 
the first collection in order to identify signs and symptoms suggestive 
of VL (e.g., fever, hepatosplenomegaly, pallor, and pancytopenia). In 
addition to clinical reassessment, the serological tests and MST were 
repeated in 68 of the 149 subjects for whom PCR results were available 
(31 with a negative result and 37 with a positive result). 
Informed consent was obtained from all participants and the project 
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was approved by the Board of UFTM (Resolution 196/96 of the National 
Research Council, Brazilian Ministry of Health).
Polymerase chain reaction: The PCR assays were carried out at 
Fiocruz, Rio de Janeiro. For DNA extraction, 5 mL blood collected 
in EDTA was centrifuged at 4000 rpm for 10 min and the buffy coat 
(leukocyte concentrate) was collected and transferred to a 1.5 mL 
microtube. DNA was extracted from this material using the Rapid Prep 
Micro Genomic DNA Isolation kit. The nucleic acid eluted in 100 µL 
elution buffer was precipitated by adding 1/10 volume of sodium acetate 
and 2.5 volumes of absolute ethanol. This mixture was centrifuged at 
13,000 rpm. The sediment was washed in 70% ethanol and resuspended 
in 20 µL reagent water.
The PCR mixture contained 200 µM dNTPs, 0.5 U Taq DNA 
polymerase in buffer recommended by the manufacturer, 100 ng of each 
primer, 2 µL DNA extracted from the leukocyte concentrate, and 1.5 
mM MgCl2, in a final volume of 50 µL. Primers targeting the periphery 
of a conserved region of the minicircles of the mitochondrial genome, 
which amplify a fragment of 120 bp, were used (forward: 5’GGG GAG 
GGG CGT TCT GCG AA; reverse: 5’CCG CCC CTA TTT TAC ACC 
AAC CCC and 5’GGC CCA CTA TAT TAC ACC AAC CCC). Positive 
controls containing 50 ng genomic DNA of L. brasiliensis and negative 
controls (no addition of DNA) were included in each PCR assay. The 
amplification conditions were 30 cycles at 94 °C for 30 s, 50 °C for 30 
s, and 72 °C for 30 s.
The PCR products (10 µL) were analyzed by 2% agarose gel 
electrophoresis in Tris-borate-EDTA buffer in a horizontal unit. The gels 
were stained with ethidium bromide and bands were visualized under 
ultraviolet light. Reactions presenting a band of 120 bp were classified 
as positive.
Serological tests and Montenegro skin test: The following 
serological tests and MST as described by ROMERO et al. (2009) 
and SILVA et al. (2011) were used: enzyme-linked immunosorbent 
assay (ELISA) and indirect immunofluorescence test (IIFT) using 
Leishmania (Leishmania) amazonensis promastigote antigen, ELISA 
using recombinant K39 (ELISA rK39) and K26 (ELISA rK26) antigens, 
and immunochromatographic test using rK39 antigen (TRALd)22,25. 
Statistical analysis: A positive result in each diagnostic test was 
compared between the first and second evaluation by the McNemar test. 
Optical densities were compared between the two groups by the Mann-
Whitney test. Agreement between the diagnostic tests was evaluated 
by the kappa coefficient. Statistical analysis was performed using the 
Statistica 8.0 software (Statsoft, Inc., Tulsa, OK). A p value < 0.05 was 
considered to be significant.
RESULTS
Among the 149 subjects submitted to PCR, 112 (75.2%) reported no 
contact with cases of human VL, 32 (21.5%) had had contact at home 
with patients with VL for some time, and five (3.3%) had a history of 
treatment of human VL. PCR was positive in 49 (32.9%) of these subjects 
and negative in 100 (67.1%). Although the frequency of a positive PCR 
result was higher among subjects who had contact with human VL, the 
difference was not statistically significant (Table 1). With respect to 
subjects with a history of VL treatment, blood was collected from all of 
them at least six months after the end of treatment. The interval between 
VL treatment and blood collection for PCR was six months, seven months 
and five years for the three cases with a positive PCR result, and 10 
months and seven years for those with a negative PCR result.
No significant differences in the frequency of positive serological 
tests or a positive MST were observed between subjects with a positive 
and negative PCR result (Fig. 1).
In the first assessment, no association was found between the 
serological or MST results and PCR (p > 0.05). In addition, the kappa 
coefficient was ≤ 0.1 in all cases (Table 2). Clinical reassessment after 
Table 1
Result of PCR according to epidemiological history
Positive 
PCR
Negative 
PCR Total
Endemic area 32 80 112
Endemic area + contact with VL 14 18 32
History of VL 3 2 5
Total 49 100 149
VL: human visceral leishmaniasis. p > 0.05.
Fig. 1 - A) Frequency of positive serological tests in subjects with a positive PCR result. B) 
Frequency of positive serological tests in subjects with a negative PCR result. 
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three to four years showed that none of the PCR-positive subjects had 
developed VL. In the case of the 68 subjects who were submitted to 
repeat serological testing and MST, again no significant difference was 
found in the percentage of positive serological tests between subjects 
with a previously positive and negative PCR result. Agreement between 
methods continued to be low (kappa ≤ 1) and no association was observed 
between the results of PCR and serological testing (p > 0.05).
DISCUSSION
The identification of asymptomatic carriers of Leishmania in 
VL-endemic areas is becoming increasingly important for different 
reasons, including the possibility to evaluate asymptomatic subjects 
as potential reservoirs of the parasite, to determine the effectiveness of 
control measures, and to evaluate the risk of transmission through blood 
donation or vertical transmission. In addition, cases that may develop the 
disease, especially among immunodepressed patients, can be identified 
early14. However, the diagnosis of asymptomatic infection continues to 
be a challenge in epidemiological studies. The methods most frequently 
used for this purpose are serological tests, MST, and PCR. Asymptomatic 
subjects from endemic areas with a positive result in any of these tests 
have been considered to be carriers of subclinical kala-azar2,4,7,8,13.
The hypothesis of the present study was that the prospective evaluation 
of subjects with a positive PCR result for Leishmania would identify those 
who develop the disease, which was not the case. Therefore, no subject was 
identified during the incubation period of VL. In addition, an association 
was expected between the results of serology and PCR, with simultaneous 
positivity of asymptomatic cases and conversion of the MST in initially 
positive subjects over time. However, low agreement between the results of 
PCR and serological testing was observed in all assessments. Furthermore, 
monitoring of the frequency of MST conversion showed no difference 
between PCR-positive and -negative subjects.
In light of this, the presence of subjects with a positive 
immunochromatographic test, a frequent bedside test that shows good 
diagnostic performance for classical cases of VL, should be emphasized3. 
In the present study, subjects with a positive TRALd did not develop the 
disease, irrespective of the PCR result, as observed in other studies15,16.
In the group treated for VL, a positive PCR result was observed in 
three subjects six months or more after the end of treatment. Interestingly, 
one patient presented a positive blood PCR result five years after the end 
of treatment. This finding suggests the persistence of the parasite even 
after specific treatment, in agreement with the literature21,24.
One limitation of the present study was the exclusive use of genus-
specific PCR. Although subjects from a VL-endemic area where cases 
of tegumentary leishmaniasis are rare were studied, the possibility that 
PCR-positive subjects were infected with some dermatotropic Leishmania 
species cannot be ruled out. Other trypanosomatids, such as Trypanosoma 
cruzi, can also show cross-reactivity in the PCR assay. 
The present findings are consistent with other investigations 
and highlight the difficulty in choosing a test for the diagnosis of 
asymptomatic Leishmania infection16. The low agreement between the 
results of serology and PCR has been attributed to the higher sensitivity of 
PCR since this method evaluates the direct presence of parasite DNA6,15. 
In contrast, other authors argue that the low experience with Leishmania 
primers may lead to false-positive results5. 
In conclusion, in the present study a positive genus-specific PCR 
in subjects from an endemic area did not indicate a risk of progression 
to VL and was not associated with the results of serology or MST. 
Further studies are needed to determine the best diagnostic method for 
asymptomatic Leishmania infection in VL-endemic areas and to define 
its true role in the expansion of the disease into urban areas.
RESUMO
Uso da reação em cadeia da polimerase para o diagnóstico de 
infecção assintomática por Leishmania em área endêmica de 
leishmaniose visceral
O diagnóstico de infecção assintomática por Leishmania (Leishmania) 
chagasi tem assumido crescente importância nos últimos anos. A 
expansão da leishmaniose visceral pode estar associada a outras vias 
de transmissão tais como transfusional, congênita, ou mesmo vetorial, 
sendo os indivíduos com infecção assintomática, potenciais reservatórios. 
Ademais, a identificação da infecção poderia auxiliar na condução dos 
pacientes com condições de imunossupressão (HIV, transplante, uso 
de imunomoduladores) e na avaliação da efetividade das medidas de 
controle. Neste estudo, foram avaliados clinicamente 149 indivíduos 
residentes em área endêmica de leishmaniose visceral e realizada a reação 
em cadeia da polimerase (PCR) gênero-específica, testes sorológicos e 
teste de Montenegro. Destes, 49 (32,9%) apresentaram PCR positiva, 
dos quais nenhum evoluiu com clínica de leishmaniose visceral nos 
três anos subsequentes. Não houve associação entre o resultado da 
PCR, dos exames sorológicos e do teste cutâneo. A positividade da 
PCR em indivíduos da área endêmica estudada não indicou risco de 
progressão para leishmaniose visceral e também não foi associada à 
maior positividade dos testes sorológicos.
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